Czechia, Aug. 13 -- Czechia based Merck Sharp & Dohme s.r.o. has secured contract from Fakultni nemocnice Hradec Kralove for Antineoplastic Agents - Pembrolizumab medicinal products. The value of the contract is worth 57733813500 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....